Topics

Companies Related to "Single Cell Genotyping CRISPR Transfected Neurons http I2mA50uXxf7" [Most Relevant Company Matches] RSS

02:43 EDT 24th August 2019 | BioPortfolio

Here are the most relevant search results for "Single Cell Genotyping CRISPR Transfected Neurons http I2mA50uXxf7" found in our extensive corporate database of over 50,000 company records.

Showing "Single Cell Genotyping CRISPR Transfected Neurons http I2mA50uXxf7" Companies 1–25 of 4,100+

Relevant

CRISPR Therapeutics

CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough gene-editing technology, into transformative medicines for serious human genetic diseases. Its vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. CRISPR Therapeutics is a Swiss company with operations in London, UK. www.crisprtx.com ...


Inscripta

Inscripta is a gene editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, single cell engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene editing tools (instruments, reagents, ...

Altogen Biosystems

Transfection is the introduction of foreign DNA or RNA molecules into cultured cells. Transfection is now a commonly used method in biological laboratories for studying gene function, modulation of gene expression, biochemical mapping, mutational analysis, and protein production. Researchers use various carrier molecules to enable non-viral gene delivery of such molecules as plasmid DNA (pDNA), me...


Hunterian Medicine LLC

Headquartered in Cambridge, Massachusetts, Hunterian Medicine LLC is a leading gene-editing company working to cure genetic diseases by correcting DNA mutations using its innovative CRISPR delivery technology. The company’s patented technology solves the problem of CRISPR delivery with a “2-for-1” genetic element that enables delivery via a ...

Neuronascent, Inc

Neuronascent began operations in a fully functional cell culture facility in Maryland. Neuronascent is in the process of developing small-molecule therapeutics for Alzheimer’s disease and depression as the main indications for its “neurogenesis” program. An orally-active, neurogenic agent could promote the formation of new neurons in key areas of the brain, replace damaged neurons, and reduc...

Intellia Therapeutics

Intellia Therapeutics was formed in 2014 to lead the industry in one of the most promising new areas of therapeutic development: gene editing and repair using CRISPR-Cas9 technology. Intellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a b...

Cell Microsystems

Cell Microsystems is an early growth stage company that develops, manufactures, and markets innovative products for single cell biology. The Company’s proprietary CellRaft™ Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the ...

Mission Bio, Inc.

Mission Bio, Inc. is innovating technologies to analyze single cells within complex biological systems, revealing critical information not observable from bulk sample analysis. With proprietary microfluidic droplet technology, Mission Bio is developing research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of ...

KSQ Therapeutics

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high confidence drug development. The company is advancing a pipeline of tumor- and immune-focused drug candidates for the treatment of cancer, across multiple drug modalities including targeted therapies, adoptive cell therapies and immuno-therapies. KSQâ...

California Stem Cell, Inc.

California Stem Cell, Inc. is a privately held company focused on the manufacture of high-purity human cells for therapeutic development and screening applications. Since its founding in 2005, CSC has developed and has intellectual property surrounding methods for scalable production of human motor neurons, neuronal progenitors, cardiac cells and liver cel...

Array-On GmbH

Array-On is an innovative enterprise engaged in biotechnology and life sciences.The company is an exclusive provider for the examination of gene variations in a large number of individuals without cross reactions on a single DNA chip. Genetic variations like SNPs, point mutations, deletions or insertions are detected simultaneously (multi-parallel genotyping).Core competence is the effective and r...

One Cell Systems, Inc.

One Cell Systems is developing and marketing a family of single cell assays that rely on microencapsulation and flow cytometry. Technology underlying these products has been developed internally and licensed from MIT and other institutions and is protected by numerous issued and pending patents. Corporate headquarters are located in Cambridge, MA and include a Cell Screening Service Center eq...

ERS Genomics

ERS Genomics was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property held by Dr. Emmanuelle Charpentier. Non-exclusive licenses are available for research and sale of products and services across multiple fields including: research tools, kits, reagents; discovery of novel targets for therapeutic intervention; cell lines fo...

QBM Cell Science Inc

QBM Cell Science is the world's leading product and service supplier for high quality, cryopreserved primary neuronal cells from the rodent brain and spinal cord.Prepared from freshly isolated and dissociated embryonic rodent CNS, these cryopreserved primary neuronal cells are frozen in vials of 1-4 million cells and comprise a normal distribution of neurons and glia (astrocytes) for that brain or...

FlowJo, LLC

FlowJo, LLC is a privately owned life sciences software company in Ashland, Oregon. Based on technology developed at Stanford, the company was founded in 1997 and provides the leading analysis platform for single-cell flow cytometry analysis. Their software innovations enable collaboration, discovery, high-throughput analysis, and data leadership in single...

Transnetyx, Inc.

Transnetyx is your molecular diagnostics company. Our automated genotyping service screens for transgenic, knock-out, and knock-in mutations in biopsies. We replace traditional genotyping with high throughput automation that allows your lab to save money and resources, increase staff productivity, and better focus on research goals.

Ncardia

Ncardia (www.ncardia.com) believes that stem cell technology will help to get better medicines to patients faster. The company develops, produces and commercializes highly predictive human cellular assay systems for safety and efficacy testing. The cardiac product portfolio encompasses a broad panel of hiPSC derived Cardiomyocytes (Pluricyte®, Cor.4UÂ...

Gene Security Network

GSN’s proprietary Parental Support™ technology is the first to leverage data informatics to deliver highly accurate single cell testing for chromosome abnormalities and genetic diseases. Parental Support uses genetic information from the parents, as well as HapMap data from the Human Genome Project, to clarify the typically noisy measurements from a ...

InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was complet...

Celsee, Inc.

Celsee, Inc., a privately held company in the Ann Arbor, Michigan area, is breaking through the traditional barriers of single-cell analysis and delivering clinical-grade technology designed to support the life sciences revolution and precision medicine. Based on a gentle, gravity-induced, micro-well isolation technique, the patented technology forms the f...

Trophos SA

Trophos is a biopharmaceutical company committed to the discovery and development of novel therapeutic compounds to treat neurodegenerative diseases.Trophos has a fully integrated pre-clinical and clinical capability. Our discovery strategy is based on screening chemical collections of small molecules on models of sick neurons, using the class of neurons affected in each type of disease. Since com...

Applied DNA Sciences Inc.

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics Inc. is an emerging company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The patent pending technology is based on discoveries made by the scientific team led by Professor Eldad Melamed, former Head of Neurology at Rabin Medic...

Caribou Biosciences

Caribou Biosciences is a developer of technology-based solutions for cellular engineering and analysis based on CRISPR-Cas9 biology. Caribou's tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology.

Caribou Biosciences, Inc.

Caribou is a leading company in CRISPR genome engineering founded by pioneers of CRISPR-Cas9 biology based on research carried out in the Doudna Laboratory at the University of California, Berkeley. Caribou’s tools and technologies provide transformative capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and...


More From BioPortfolio on "Single Cell Genotyping CRISPR Transfected Neurons http I2mA50uXxf7"

Quick Search

Corporate Database Quicklinks